Clinical Trials [clinicaltrials_resource:fdfde6e9049d5fd0a101bd914ee1a2fe]
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer [clinicaltrials:NCT00009737]clinicaltrials:NCT00022672A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia [clinicaltrials:NCT00048035]A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis. [clinicaltrials:NCT00048048]MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis [clinicaltrials:NCT00048061]DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis [clinicaltrials:NCT00048074]A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer [clinicaltrials:NCT00048126]A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer [clinicaltrials:NCT00048139]A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients [clinicaltrials:NCT00048152]A Study of Capecitabine (Xeloda) as a First-line Therapy in Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00069095]A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00069108]clinicaltrials:NCT00069121A Study of Mircera for the Treatment of Anemia in Dialysis Patients [clinicaltrials:NCT00077597]A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients [clinicaltrials:NCT00077610]A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients. [clinicaltrials:NCT00077623]ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection. [clinicaltrials:NCT00077636]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC). [clinicaltrials:NCT00077649]A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. [clinicaltrials:NCT00077766]clinicaltrials:NCT00077857Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis [clinicaltrials:NCT00080223]A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis [clinicaltrials:NCT00081471]A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients [clinicaltrials:NCT00081484]clinicaltrials:NCT00081653A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin [clinicaltrials:NCT00087568]Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation [clinicaltrials:NCT00087581]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program. [clinicaltrials:NCT00087594]PEAK Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC). [clinicaltrials:NCT00087607]clinicaltrials:NCT00087633REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy [clinicaltrials:NCT00087646]clinicaltrials:NCT00089479A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients [clinicaltrials:NCT00089492]clinicaltrials:NCT00090753A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients [clinicaltrials:NCT00090766]A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain [clinicaltrials:NCT00099177]A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease [clinicaltrials:NCT00099203]A Study of A4I Antagonist in Patients With Relapsing Multiple Sclerosis. [clinicaltrials:NCT00104143]clinicaltrials:NCT00105079A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy [clinicaltrials:NCT00106522]clinicaltrials:NCT00106535A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis [clinicaltrials:NCT00106548]
overall official [clinicaltrials_vocabulary:overall-official]
Clinical Trials [clinicaltrials_resource:fdfde6e9049d5fd0a101bd914ee1a2fe]
Bio2RDF identifier
fdfde6e9049d5fd0a101bd914ee1a2fe
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:fdfde6e9049d5fd0a101bd914ee1a2fe
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
genentech@druginfo.com
genentechclinicaltrials@druginfo.com
genetech@druginfo.com
global.rochegenentechtrials@roche.com
last name [clinicaltrials_vocabulary:last-name]
Clinical Trials
phone [clinicaltrials_vocabulary:phone]
+1 973 235 5000
1-800-821-8590
800 821-8590
800-821-8590
888-662-6728 (U.S. Only)
role [clinicaltrials_vocabulary:role]
Study Director
identifier
clinicaltrials_resource:fdfde6e9049d5fd0a101bd914ee1a2fe
title
Clinical Trials
@en
type
label
Clinical Trials [clinicaltrials_resource:fdfde6e9049d5fd0a101bd914ee1a2fe]
@en